Due to the limited number of reports concerning their association with particular dysplastic and neoplastic lesions, the oncogenic potential of so-called rare or novel human papillomavirus (HPV) types is still unclear. Cytologic smears or biopsy specimens from 538 patients were analyzed for dysplastic or neoplastic lesions and HPV infection. The HPV detection and typing system utilized allowed identification of all mucosal HPVs amplifiable by L1 polymerase chain reaction. Considering only patients infected with a single HPV type (n Å 329), rare or novel HPVs (HPV-59, HPV-61, HPV-62, HPV-66, HPV-70, HPV-73, MM4, MM7, MM8, CP6108, and CP8304) were detected in 28% of normal specimens (n Å 46), none of condylomatous lesions (n Å 44), 12% of low-grade squamous intraepithelial lesions (SILs) (n Å 42), 8% of high-grade SILs (n Å 142), and 4% of cervical cancers (n Å 54). Prevalence and oncogenic potential of distinct rare HPV types seems to be higher than previously assumed.
Most genital dysplastic and neoplastic lesions are associated in genital cancer. Moreover, the E6 and E7 gene products of these viruses do not interact with cell-cycle proteins, such as with human papillomavirus (HPV) infections. General acceptance of the etiologic role of at least particular HPV types p53 and Rb105, respectively, further suggesting the low oncogenicity of these HPV types (reviewed in [2] ). results mainly from epidemiologic studies that have identified HPV infection as an important risk factor for precancerous For many other HPVs (including novel and rare HPVs), the oncogenic potential is still unknown, due to the limited number lesions and cancer of the cervix uteri and from the oncogenic potential demonstrated for the HPV-encoded proteins E6 and of reports concerning their association with particular dysplastic and neoplastic lesions. The identification of some of these E7 [1 -3] .
Forty-five HPV types are known to infect mucosal epithelia HPV types in cervical carcinomas [6, 7] indicates that oncogenic HPVs may be present among rare HPVs as well. To predominately in the genital tract and thus are referred to as genital HPVs [4] . Development of genital cancer was shown to fully understand the natural history of cervical carcinoma, it is important to consider all genital HPV types. Furthermore, it be associated particularly with HPV-16 and HPV-18. These HPV types were thus considered high-risk. Other HPV types, has been suggested that due to the different oncogenicities of individual HPVs, decisions about patient care based on the such as HPV-45, HPV-52, HPV-56, and HPV-58, are less prevalent, but due to their comparatively frequent detection in genital HPV type found in genital swabs may be possible in the future [8] . However, patient care depending on HPV type identificacancer, they also belong to the group of HPV types with high risk for tumor induction [5, 6] . HPV-31, HPV-33, HPV-35, and tion would require characterization of the oncogenic potential of all HPV types. others are usually referred to as HPVs with an intermediate risk for tumor induction, since they are detected more frequently To obtain more information about prevalence and association of rare HPV types with cytologic and histologic aberrations, in high-grade squamous intraepithelial lesions (HSILs) than in cancers. In contrast, HPV-6 and HPV-11, responsible for the we screened clinical material from the genitourinary tract using our recently published HPV typing system, which allows idengreat majority of condylomatous lesions, were found very rarely tification of all HPV types amplified by L1 consensus polymerase chain reaction (PCR) [9] . 253 JID 1998;178 (July) Concise Communications [10] . Smears and biopsy specimens for HPV detection were placed 40, HPV-42, HPV-43, and HPV-44 with cancer induction was considered to be very low [5, 6, 12, 13]. However, in these studies, several other HPV types could not be excluded as risk Results factors for oncogenic progression, since not all HPV types then known to cause genital lesions were included. Moreover, HPV infections were detected in 56 (32%) of 173 patients with normal cytology or histology (unsuspicious or inflammaseveral novel HPV types were discovered in the meantime [4] . As shown in many previous studies, we also found HPV-16 tory lesions), in 74% of patients with LSILs (n Å 68), and in 88% of patients with HSILs (n Å 187). Furthermore, HPV to be the most prevalent HPV type in HSILs and cervical cancer. HPV types known to have high or intermediate risk DNA was detected in tissue specimens from 60 of 62 patients with carcinoma of the cervix uteri and in 47 (98%) of 48 for tumor induction were identified in 91% of the HPV-positive HSILs or cancer lesions. In 9% of such lesions, we detected patients with condylomatous lesions. All HPV DNA -negative specimens were checked for sufficient DNA or PCR inhibitory only low-risk HPVs or rare HPV types, the oncogenic potential of which remains unknown. substances by b-globin PCR.
In specimens from 49 patients, more than one HPV type HPV isolate MM4 (also known as PapW13B) has been identified by Manos et al. [7] in a coinfection with HPV-53 in a was detected (45 double infections, 4 infections with three HPV types). Since in such cases cytologic or histologic alterations patient with normal cytology. The virus was found predominately in low-grade dysplastic lesions but was also detected in cannot be specifically attributed to one HPV type, only patients showing infections with a single HPV type were considered in 3 of 30 HPV-positive tumors from patients in the Philippines [7] . The identification of MM4 but no other HPV type in biopsy table 1. Among patients with HSILs and cervical carcinoma, HPV-16 was detected most frequently (95/196 cases, 48%). In specimens of 2 Mexican patients with cervical cancer in the present study supports the high oncogenic potential of this HPV 127 (65%) of these 196 patients, high-risk HPV types were / 9d4a$$jy27 05-28-98 08:11:50 jinfas UC: J Infect type and indicates that cervical cancer associated with this HPV In agreement with a previous study [7] , HPV-73, another rare HPV type (formerly designated MM9 or PAP238A), was type is not restricted to the Philippines or eastern Asia.
In two other carcinomas, HPV-6 was the only HPV type detected in both patients with HSILs and normal cytology. Constant detection of HPV-73 in cervical swabs from 1 patient detected. Although HPV-16, HPV-18, HPV-31, and HPV-33 were not detected with type-specific primers, the presence of who progressed from mild to severe dysplasia over 1.5 years indicates persistence of HPV-73 infection and supports associaother oncogenic HPVs that were not well amplified cannot be excluded completely. In situ analysis of tumor cells for HPVtion of HPV-73 with malignant progression. Other single rare or novel HPVs in HSILs identified in the 6 DNA should prove the possible association of HPV-6 with tumor induction. present study include HPV-59, HPV-61, HPV-62, CP6108, and CP8304. Furthermore, coinfection with HPV-66 and HPV-53 was found in a patient with severe cervical dysplasia (CIN III). Since, to our knowledge, HPV-53 has not yet been found in / 9d4a$$jy27 05-28-98 08:11:50 jinfas UC: J Infect
